PERSEUS SENOLYTIX
Live / Applied — Non-final action mailed (as of 22 Jan 2026)
What this means for you
Not registered yet, but its 22 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99351616
- Mark type
- Design + words
- Filed
- 22 Aug 2025
- Attorney of record
- Jared L. DuJack
Goods and services
- Class 042 — Scientific and technological services: Medical research services; Medical research services, namely, anti-cancer and anti-aging services; Medical research services, namely, prevention and treatment of cancer and age-related disorders; Medical advisory services; Medical advisory services, namely, anti-cancer and anti-aging services; Medical advisory services, namely, prevention and treatment of cancer and age-related disorders; Medical testing services; Medical testing services, namely, anti-cancer and anti-aging services; Medical testing services, namely, prevention and treatment of cancer and age-related disorders; Medical services in the field of anti-cancer and anti-aging; Medical services in the field of senescent cells; Medical services in the field of cancer and age-related disorders; Biopsy services; Biopsy services related to cancer; Biopsy services related to biologic age; Biopsy services related to biological age scoring; Biopsy services related to determining a number or percentage of senescent cells; Laboratory services; Laboratory services related to cancer; Laboratory services related to biologic age; Laboratory services related to biological age scoring; Laboratory services related to determining a number or percentage of senescent cells; Non-invasive testing; Non-invasive testing related to cancer; Non-invasive testing related to biologic age; Non-invasive testing related to biological age scoring; Non-invasive testing related to determining a number or percentage of senescent cells; Prevention of cancer; Treatment of cancer; Prevention of radiation damage; Treatment of radiation damage; Prevention of radiation related diseases; Treatment of radiation related diseases
- Class 044 — Medical, beauty and agricultural services: Anti-cancer therapy; Anti-cancer services;Anti-cancer research; Anti-aging therapy; Anti-aging services; Anti-aging research; Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of cancer and age-related diseases; Testing, inspection, research, or development of pharmaceutical preparations for cancer therapy and age therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; Peptides for use in cancer and age-related diseases; Peptides for use in skin conditions; Anti-cancer peptides; Anti-aging peptides; Peptides for use in prevention of radiation damage; Peptides for use in treatment of radiation damage; Peptides for use in prevention of radiation related diseases; Peptides for use in treatment of radiation related diseases; Biologic age scoring; Statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, anti-cancer and anti-aging services; Medical services, namely, prevention and treatment of cancer and age-related disorders
Owner
- SENOTHERAPEUTIX, Inc., Surfside, FL, US
Prosecution history
- 22 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jan 2026 — NON-FINAL ACTION E-MAILED
- 22 Jan 2026 — NON-FINAL ACTION WRITTEN
- 13 Jan 2026 — ASSIGNED TO EXAMINER
- 12 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 12 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 22 Aug 2025 — NEW APPLICATION ENTERED